Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech To Distribute Partek's Genomics Suite Software


This story was originally published on Feb. 4.

Life Technologies will offer Partek's Genomics Suite software for analyzing next-generation sequence data under a distribution agreement the companies signed today.

The software can be used to analyze data from a number of applications, including the sequencing of genomic DNA, RNA-seq, and ChIP-seq, and is also compatible with all other next-gen sequencing systems. According to the company, the software includes embedded tools for alignment, quality control analysis, robust statistics and clustering, and allows researchers to identify biomarkers, pathways, and patterns in the data.

Partek also inked a distribution agreement with Ion Torrent this week, and its software will be available through the Ion Torrent website (IS 2/3/2011).

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.